B 
Beauty Farm Medical & Health Industry 2373.HK · HKD
Consumer Discretionary · HKEX · 🇭🇰 Hong Kong
18.35
+0.38%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥3.00bn
FY2019FY2025
Net income
CN¥317.6m
FY2019FY2025
Free cash flow
CN¥932.0m
FY2019FY2025
Shareholders' equity
CN¥1.02bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | CN¥3.00bn | CN¥2.20bn | CN¥1.84bn | CN¥1.40bn | CN¥1.53bn | CN¥1.29bn | CN¥1.40bn |
| Gross profit | CN¥1.47bn | CN¥1.02bn | CN¥837.2m | CN¥615.1m | CN¥714.4m | CN¥599.8m | CN¥708.3m |
| Research and development | CN¥41.9m | CN¥30.9m | CN¥29.2m | CN¥26.7m | CN¥15.4m | CN¥10.9m | CN¥9.1m |
| Operating income | CN¥459.5m | CN¥275.8m | CN¥249.6m | CN¥130.3m | CN¥238.2m | CN¥182.8m | CN¥207.2m |
| Net income | CN¥317.6m | CN¥195.8m | CN¥184.8m | CN¥88.4m | CN¥165.8m | CN¥129.4m | CN¥140.3m |
| Diluted earnings per share | 1.36 | 0.85 | 0.80 | 0.44 | 0.83 | 0.56 | 0.61 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | CN¥5.05bn | CN¥3.66bn | CN¥2.83bn | CN¥2.14bn | CN¥2.12bn | CN¥1.80bn | CN¥1.82bn |
| Cash and short-term investments | CN¥2.57bn | CN¥1.57bn | CN¥1.35bn | CN¥780.3m | CN¥928.5m | CN¥687.1m | CN¥463.7m |
| Total liabilities | CN¥3.98bn | CN¥2.83bn | CN¥2.11bn | CN¥1.96bn | CN¥1.90bn | CN¥1.68bn | CN¥1.77bn |
| Debt | CN¥1.29bn | CN¥626.0m | CN¥482.5m | CN¥450.3m | CN¥441.7m | CN¥441.9m | CN¥569.0m |
| Shareholders' equity | CN¥1.02bn | CN¥809.4m | CN¥687.1m | CN¥161.7m | CN¥220.5m | CN¥120.7m | CN¥47.3m |
| Shares outstanding | 233m | 230m | 231m | 200m | 200m | 231m | 231m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥999.1m | CN¥682.6m | CN¥536.0m | CN¥327.3m | CN¥574.0m | CN¥583.1m | CN¥463.3m |
| Capital spending | −CN¥67.1m | −CN¥97.8m | −CN¥136.4m | −CN¥120.6m | −CN¥114.1m | −CN¥57.8m | −CN¥107.8m |
| Free cash flow | CN¥932.0m | CN¥584.8m | CN¥399.5m | CN¥206.7m | CN¥459.9m | CN¥525.3m | CN¥355.5m |
| Dividends paid | −CN¥122.3m | −CN¥96.4m | −CN¥74.5m | −CN¥175.0m | −CN¥69.5m | −CN¥91.5m | −CN¥80.7m |
Latest quarters
By quarter end
| Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥1.88bn | CN¥1.54bn | CN¥1.46bn | CN¥1.23bn | CN¥974.9m | CN¥949.6m | CN¥888.5m | CN¥772.1m |
| Gross profit | CN¥966.5m | CN¥752.1m | CN¥719.8m | CN¥561.9m | CN¥457.7m | CN¥427.6m | CN¥409.7m | CN¥346.0m |
| Operating income | CN¥334.5m | CN¥235.4m | CN¥224.1m | CN¥136.0m | CN¥139.7m | CN¥116.4m | CN¥125.1m | CN¥92.9m |
| Net income | CN¥222.2m | CN¥161.9m | CN¥155.7m | CN¥96.9m | CN¥98.9m | CN¥89.0m | CN¥95.8m | CN¥75.4m |
| Diluted earnings per share | 0.91 | 0.69 | 0.67 | 0.42 | 0.43 | 0.38 | 0.41 | 0.38 |
| Cash from operations | CN¥551.0m | CN¥602.0m | CN¥410.0m | CN¥492.0m | CN¥190.0m | CN¥403.0m | CN¥190.0m | CN¥217.0m |
| Capital spending | — | −CN¥31.0m | −CN¥35.0m | −CN¥75.0m | −CN¥75.0m | −CN¥110.0m | −CN¥41.0m | −CN¥76.0m |
| Free cash flow | — | CN¥571.0m | CN¥375.0m | CN¥417.0m | CN¥115.0m | CN¥293.0m | CN¥149.0m | CN¥141.0m |
| Total assets | CN¥6.43bn | CN¥5.05bn | CN¥4.31bn | CN¥3.66bn | CN¥2.92bn | CN¥2.83bn | CN¥2.67bn | CN¥2.14bn |
| Cash and short-term investments | CN¥2.41bn | CN¥2.57bn | CN¥2.00bn | CN¥1.57bn | CN¥1.34bn | CN¥1.35bn | CN¥1.26bn | CN¥780.3m |
| Debt | CN¥356.7m | CN¥1.29bn | CN¥779.1m | CN¥626.0m | CN¥515.4m | CN¥482.5m | CN¥454.0m | CN¥450.3m |
| Shareholders' equity | CN¥1.41bn | CN¥1.02bn | CN¥881.0m | CN¥809.4m | CN¥710.8m | CN¥687.1m | CN¥611.8m | CN¥161.7m |
Financial ratios
Data as of 14 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 49.1% | 46.3% | 45.6% | 43.9% | 46.8% | 46.6% |
| Operating margin | 15.1% | 12.1% | 14.6% | 9.5% | 15.7% | 14.3% |
| Net margin | 10.6% | 8.9% | 10.1% | 6.3% | 10.9% | 10.0% |
| Return on equity | 31.1% | 24.2% | 26.9% | 54.6% | 75.2% | 107.2% |
| Return on assets | 6.3% | 5.3% | 6.5% | 4.1% | 7.8% | 7.2% |
| Free cash flow yield | 25.0% | 20.2% | 15.8% | 11.1% | 19.6% | 17.2% |
| Revenue growth | 16.7% | 19.9% | 31.2% | -8.2% | 18.5% | 7.0% |
| Earnings growth | 39.0% | 5.9% | 109.2% | -46.7% | 28.2% | 7.6% |
| Current ratio | 0.98x | 0.80x | 0.94x | 0.65x | 0.71x | 0.62x |
| Debt to equity | 0.92x | 0.39x | 0.21x | 0.80x | -5.56x | 1.05x |
| Equity ratio | 20.3% | 22.1% | 24.3% | 7.6% | 10.4% | 6.7% |
| Interest coverage | 14.05x | 11.25x | 12.62x | 6.28x | 11.53x | 8.27x |
| R&D as a share of sales | 1.4% | 1.4% | 1.6% | 1.9% | 1.0% | 0.8% |
| Buybacks as a share of market value | -1.5% | 0.6% | -15.4% | -0.4% | 13.4% | 0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 28.9% | 18.4% | — |
| Operating income | 52.2% | 20.2% | — |
| Net income | 53.2% | 19.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 47.9% | 46.7% | 46.7% | — |
| Operating margin | 14.1% | 13.2% | 13.6% | — |
| Net margin | 9.9% | 9.3% | 9.6% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Price to earnings | 17.3 | 18.1 | 12.0 |
| Price to sales | 1.8 | 1.6 | 1.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 19 Aug 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Paid in the year | 0.619 | 0.52 | 0.47 | 0.39 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.